Tag: Pah treatment

An estimated 500 to 1,000 new cases of pulmonary arterial hypertension (PAH) are diagnosed each year in the U.S.. For those prescribed Endobloc, understanding how to use Endobloc correctly is crucial for managing this condition. This medication, containing the active ingredient Ambrisentan, helps improve exercise ability and delay disease progression.

According to data from clinical trials like STELLAR, a significant percentage of patients taking Winrevair reported experiencing side effects, most commonly headache and nosebleeds. This article details what are the side effects of the drug Winrevair, both common and severe, to help patients and caregivers understand the potential risks associated with this pulmonary arterial hypertension (PAH) treatment.